Novel strategies direct immune system to attack recurrent, hard-to-treat blood cancers

Novel treatments that harness the body's own immune cells to attack cancer cells demonstrate safe and durable responses in patients with relapsed and treatment-resistant blood cancers, according to data presented today at the 56th American Society of Hematology Annual Meeting and Exposition. Therapies designed to target the immune system and ignite the body's own disease-fighting mechanisms have become an increasingly promising field of study, particularly in blood cancers.

http://ift.tt/1wSiuFo